NCT06597318

Brief Summary

currently, PROMs and PREMs are not routinely collected and compared among medical inpatients of Swiss university hospitals, nor is a standard set of PROMs and PREMs available for use in Swiss hospitals. The project aims to examine trends in patient-reported outcomes (PROMs), including symptoms, quality of life, and distress, in multimorbid hospitalized patients from admission to 30 days post-discharge. It will also investigate whether PROMs at discharge are linked to the risk of readmission or emergency visits and explore how these outcomes differ in patients who receive low-value care. Additionally, the project will assess the relationship between patient-reported experiences (PREMs) and the provision of low-value care during the hospital stay.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2023

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

August 21, 2024

Completed
29 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

2.2 years

First QC Date

August 21, 2024

Last Update Submit

September 12, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Correlation of PROMS with the risk of readmission

    The primary objective of the project is to explore trends in PROMs (using the Edmonton Symptom Assessment System (ESAS-r), the EQ-5D-5L index,45 and the National Comprehensive Cancer Network (NCCN) distress thermometer) of multimorbid medical hospitalized patients, from admission until 30-days post-discharge. The patients-reported outcomes will consist of patients-reported symptoms, quality of life and distress

    Day 1, Day 3, at the day of discharge (approximately day 8) and Day 30 after discharge from Hospital

Secondary Outcomes (3)

  • Correlation of PROMs at discharge and risk of hospital readmission or ED visits

    Day 30 after discharge from hospital

  • Exploration of PROMs in patients who receive low-value care

    Day 1, Day 3, at the day of discharge (approximately day 8) and Day 30 after discharge from Hospital

  • Explore PREMs

    Since 24 hours after beginning of the hospitalization up to Discharge from Hospital (approximately day 8)

Study Arms (1)

multimorbid patients in general internal medicine divisions of all five Swiss university hospitals

Other: Hospitalization

Interventions

The investigators collect PROMs amongst up to 1000 patients in general internal medicine divisions of all five Swiss university hospitals

multimorbid patients in general internal medicine divisions of all five Swiss university hospitals

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with 2 or more chronic diseases, hospitalized in general internal medicine divisions of all five Swiss university hospitals

You may qualify if:

  • eligible for the LUCID registry (CER-VD AO\_2023-00029) \[Age ≥ 18 years, hospitalized in one of the five participating university hospitals (Geneva, Lausanne, Bern, Zürich, Basel), after 01.01.2014, and admitted to general internal medicine wards
  • Multimorbid patients (2 or more chronic diseases, defined as chronic conditions defined by international classification of diseases, 10th revision, codes with an estimated expected duration of at least 6 months or based on a clinical decision.
  • Acute illness
  • Signature of study specific informed consent

You may not qualify if:

  • Not able to speak French, German or English
  • Foreseen length of stay of less than 4 days (estimated by study collaborators)
  • Incapacity of discernment, i.e. cognitive impairment which could interfere with the ability to fill in PROMs tools

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lausanne University Hospital

Lausanne, Canton of Vaud, 1005, Switzerland

RECRUITING

MeSH Terms

Interventions

Hospitalization

Intervention Hierarchy (Ancestors)

Patient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Jerome Stirnemann, MD

    University Hospital, Geneva

    PRINCIPAL INVESTIGATOR
  • Carole Aubert, MD

    Bern University Hospital

    PRINCIPAL INVESTIGATOR
  • Florence Vallelian Cervetto, MD

    Zürich University Hospital

    PRINCIPAL INVESTIGATOR
  • Stefano Bassetti, MD

    Basel University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marie Méan, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Senior Physician

Study Record Dates

First Submitted

August 21, 2024

First Posted

September 19, 2024

Study Start

July 1, 2023

Primary Completion

August 31, 2025

Study Completion

October 1, 2025

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations